From: Overexpression of c-erb B2 is a negative prognostic factor in anaplastic astrocytomas
Case no. | Age (years)/Sex | Prior brain tumor | KPS | Resection grade | Radiotherapy | Postoperative survival (months) |
---|---|---|---|---|---|---|
1 | 57/M | No | 80 | Partial | 1.8 Gy × 30 | 16.6 |
2 | 34/F | No | 80 | Partial | 1.8 Gy × 30 | 29.4 |
3 | 44/M | Grade II astrocytoma | 90 | Partial | No | 41.5 |
4 | 28/F | No | 90 | GTR | 1.8 Gy × 30 | 55.4 |
5 | 57/F | No | 70 | Partial | 1.8 Gy × 30 | 5.6 |
6 | 50/M | Grade II astrocytoma | 80 | Partial | 1.8 Gy × 30 | 23.7 |
7 | 67/F | No | 80 | Partial | 1.8 Gy × 30 | 12.1 |
8 | 39/F | No | 70 | GTR | N.D. | N.D. |
9 | 53/M | No | 70 | Partial | 1.8 Gy × 30 | 24.6 |
10 | 78/F | No | 50 | Biopsy | 3.0 Gy × 13 | 9.8 |
11 | 34/F | No | 80 | Partial | 1.8 Gy × 30 | 95.8+ |
12 | 42/M | No | 70 | GTR | 1.8 Gy × 30 | 93.6+ |
13 | 78/M | No | 50 | Biopsy | No | 1.9 |
14 | 40/M | No | 70 | GTR | 1.8 Gy × 30 | 53.9 |
15 | 47/M | Grade II astrocytoma | 90 | GTR | No | 90+ |
16 | 49/M | No | 50 | Biopsy | No | 0.1 |
17 | 64/M | No | 70 | GTR | 1.8 Gy × 30 | 76.1+ |
18 | 48/F | No | 80 | GTR | 1.8 Gy × 30 | 8.3 |
19 | 57/F | No | 80 | Partial | 1.8 Gy × 30 | 63.8+ |
20 | 72/M | No | 60 | Biopsy | 1.8 Gy × 30 | 11.1 |
21 | 36/M | No | 70 | Partial | 3.0 Gy × 13 | 11.2 |
22 | 56/F | No | 70 | Partial | 2.0 Gy × 30 | 17.9 |
23 | 53/F | No | 80 | GTR | 2.0 Gy × 30 | 59.8+ |
24 | 44/F | No | 80 | GTR | No | 59.8+ |
25 | 37/M | No | 80 | GTR | No | 54.6+ |
26 | 58/M | No | 80 | Partial | 1.8 Gy × 30 | 28.6 |
27 | 32/F | No | 70 | Partial | 2.0 Gy × 30 | 16.2 |
28 | 38/M | No | 80 | Partial | 2.0 Gy × 30 | 35.3+ |
29 | 71/M | No | 50 | Biopsy | 3.0 Gy × 13 | 10.2 |
30 | 49/M | No | 70 | Partial | 2.0 Gy × 30 | 30.6+ |
31 | 44/M | Grade II astrocytoma | 80 | Partial | 1.8 Gy × 30 | 39.4+ |